Group 1 - The company held the 18th meeting of the 11th Supervisory Board on August 15, 2025, with a total of 5 supervisors present, including 3 in person and 2 via telecommunication [1][2] - The Supervisory Board unanimously approved the adjustment of the list of incentive objects and the number of restricted stock grants under the 2025 Restricted Stock Incentive Plan, confirming compliance with relevant laws and regulations [1][2] - The adjusted incentive objects meet the conditions set forth in the "Management Measures for Equity Incentives of Listed Companies" and the company's incentive plan, ensuring the legality and validity of their qualifications [1][2] Group 2 - The board of directors determined the grant date in accordance with relevant regulations, and both the company and the incentive objects have not encountered any disqualifying circumstances [2] - The Supervisory Board agreed to grant 14.24 million shares of restricted stock at a price of 3.21 yuan per share, with all votes in favor [2]

Core Points - The company has approved the initial grant of the 2025 Restricted Stock Incentive Plan, with the grant date set for August 15, 2025 [2][3] - The incentive plan's recipients meet the eligibility criteria outlined in the plan and relevant regulations [2][3] - The committee has verified that none of the recipients fall under disqualifying conditions as specified by the regulatory framework [2][3] Summary by Sections - **Incentive Plan Approval** - The board's compensation and assessment committee has conducted a thorough review and approved the initial grant of the 2025 Restricted Stock Incentive Plan [2] - The grant date is confirmed as August 15, 2025 [3] - **Eligibility of Recipients** - All recipients of the restricted stock grants comply with the conditions set forth in the 2025 incentive plan and relevant regulations [2][3] - The recipients do not include any individuals disqualified under the specified criteria, ensuring the integrity of the incentive program [2][3] - **Regulatory Compliance** - The committee has ensured that the recipients do not fall into any of the disqualifying categories outlined by the China Securities Regulatory Commission and other relevant laws [2][3]

Core Viewpoint - Jiangsu Chengxing Phosphate Chemical Co., Ltd. has initiated a stock incentive plan for 2025, which includes adjustments and the first grant of restricted stocks to incentivize key personnel and enhance company performance [1][7][12]. Summary by Sections Independent Financial Advisor Report - The independent financial advisor confirms that the stock incentive plan has been approved and complies with relevant laws and regulations [5][12]. - The plan involves granting restricted stocks to directors, senior management, core personnel, and high-potential employees [8][12]. Approval Process - The necessary approvals for the stock incentive plan have been obtained, including resolutions from the board of directors and the supervisory board [6][7]. - The company has publicly disclosed the list of incentive recipients and received no objections during the public notice period [6][7]. Adjustments to the Incentive Plan - The initial list of 86 recipients has been adjusted to 79 due to 7 individuals voluntarily waiving their rights to the restricted stocks [8][9]. - The total number of restricted stocks granted has been reduced from 16 million shares to 14.24 million shares [8][9]. Granting Conditions and Schedule - The incentive plan's effective period lasts up to 66 months, with a vesting schedule that includes a 12-month, 24-month, and 36-month lock-up period for the granted stocks [9][10]. - The conditions for lifting the restrictions on the stocks include meeting specific performance criteria and compliance with legal regulations [8][10]. Financial Impact - The independent financial advisor emphasizes the need for accurate accounting of the stock incentive plan's impact on the company's financial status and operating results, in accordance with accounting standards [12]. Conclusion - The independent financial advisor concludes that the adjustments and initial grants of the stock incentive plan have met all necessary legal and regulatory requirements, and the company will proceed with the required disclosures and follow-up procedures [12].

江苏澄星磷化工股份有限公司 办法》"）等法律、法规及《江苏澄星磷化工股份有限公司章程》 （以下简称"《公 司章程》"）的规定，江苏澄星磷化工股份有限公司（以下简称"公司"）监事会 对公司 2025 年限制性股票激励计划（以下简称"本次激励计划"）首次授予激励 对象认真核实后，发表如下意见： 部限制性股票外，本次获授限制性股票的其他首次授予激励对象与公司 2025 年 第三次临时股东大会审议通过的公司《2025 年限制性股票激励计划（草案）》 （以 监事会关于公司 2025 年限制性股票激励计划 首次授予激励对象的核查意见（授予日） 根据《公司法》 《证券法》 《上市公司股权激励管理办法》 （以下简称"《管理 （3）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施； （4）具有《公司法》规定的不得担任公司董事、高级管理人员的情形的； （5）法律法规规定不得参与上市公司股权激励的； 下简称"《激励计划》"）中确定的激励对象条件相符； 象的情形： （1）最近 12 个月内被证券交易所认定为不适当人选； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （6 ...

证券代码：600078 证券简称：澄星股份 公告编号：临 2025-053 江苏澄星磷化工股份有限公司 关于调整公司 2025 年限制性股票激励计划相关事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏澄星磷化工股份有限公司（以下简称"公司"）于 2025 年 8 月 15 日召 开第十一届董事会第二十二次会议，审议通过了《关于调整公司 2025 年限制性 股票激励计划相关事项的议案》，现将有关事项说明如下： 一、2025 年限制性股票激励计划已履行的决策程序和信息披露情况 过了《关于 <公司 ensp="ensp" 及其摘要="及其摘要" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 的议案》、《关 于 <公司 ensp="ensp" 年限制性股票激励计划实施考核管理办法="年限制性股票激励计划实施考核管理 办法"> 的议案》以及《关于提 请股东大会授权董事会办理公司 2025 年限制性股票激励计划相关事宜的议案》 等议案。 同日，公司召开第十一届监事会第十七次会议，审议通过了《关于 <公司 ...

Group 1 - The core point of the announcement is that Guangge Technology has launched an incentive plan involving the grant of restricted stocks to 51 individuals, with a total of up to 750,900 shares, accounting for 1.14% of the company's total share capital of 66 million shares [1] - The restricted stock grant price is set at 15 yuan per share, with a maximum validity period of 48 months from the date of grant [1] - The company's revenue composition for the year 2024 is predominantly from the manufacturing of computers, communications, and other electronic equipment, which accounts for 99.99% of total revenue, while other businesses contribute only 0.01% [1] Group 2 - As of the latest report, Guangge Technology has a market capitalization of 2 billion yuan [2]

Group 1 - The company, Suzhou Guangge Technology Co., Ltd., is holding its second extraordinary general meeting of shareholders in 2025 on September 1, 2025, at 14:00 [2][4] - The meeting will adopt a combination of on-site and online voting methods, with online voting available through the Shanghai Stock Exchange's system [1][2] - Shareholders must register to attend the meeting, with registration open on August 28, 2025, and specific documentation required for both individual and corporate shareholders [5][6] Group 2 - The agenda includes several key proposals, such as the 2025 Restricted Stock Incentive Plan and the 2025 Employee Stock Ownership Plan, which require shareholder approval [2][3] - The meeting will also address amendments to the regulations governing controlling shareholders and insider information management [3][4] - Shareholders must complete voting on all proposals before submission, and duplicate votes will be disregarded, with the first vote counted as the final decision [4][3]

浙江天册（深圳）律师事务所 关于 广东乐心医疗电子股份有限公司 的限制性股票、第二个解除限售期解除限售条件成就、第 二个归属期归属条件成就相关事项的 法律意见书 广东省深圳市南山区科发路 222 号康泰创新广场 34 层 邮编：518057 电话：0755-26907494 传真：0755-26906383 网址：http://www.tclawfirm.com 法律意见书 致：广东乐心医疗电子股份有限公司 浙江天册（深圳）律师事务所（以下简称本所）受广东乐心医疗电子股份有 限公司（以下简称乐心医疗或公司）委托，担任公司本次实施 2023 年限制性股 票激励计划（以下简称本次激励计划）的专项法律顾问。本所根据《中华人民共 和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称 《证券法》）、《上市公司股权激励管理办法》（以下简称《管理办法》）等法 律、行政法规、部门规章及其他规范性文件（以下简称法律法规）及《广东乐心 医疗电子股份有限公司章程》（以下简称《公司章程》）、《广东乐心医疗电子 股份有限公司 2023 年限制性股票激励计划（草案）》（以下简称《激励计划（草 案）》）的有关规定，就公司 ...

北京市汉坤律师事务所 关于 苏州光格科技股份有限公司 法律意见书 汉坤（证）字[2025]第[35654-3]-O-1 号 中国北京市东长安街 1 号东方广场 C1 座 9 层 100738 电话：(86 10) 8525 5500；传真：(86 10) 8525 5511 / 8525 5522 北京 ? 上海 ? 深圳 ? 香港 ? 海口 ? 武汉 ? 新加坡 ? 纽约 ? 硅谷 www.hankunlaw.com 北京市汉坤律师事务所 法律意见书 北京市汉坤律师事务所 关于苏州光格科技股份有限公司 法律意见书 汉坤（证）字[2025]第[35654-3]-O-1 号 致：苏州光格科技股份有限公司 北京市汉坤律师事务所（以下简称"本所"）接受苏州光格科技股份有限公司 （以下简称"公司"或"光格科技"）的委托，担任公司2025年限制性股票激励计 划（以下简称"本次激励计划"）的法律顾问，并根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》 "）、 《上市公司股权激励管理办法》 （以下简称"《管理办法》"）等相关法律法规、规 章及其他规范性文件和《苏州光格 ...

Core Points - The company, Suzhou Guangge Technology Co., Ltd., has proposed a restricted stock incentive plan for 2025, aiming to attract and retain talent while aligning the interests of shareholders, the company, and individuals [1][6][24] - The plan involves granting up to 750,900 restricted shares, representing approximately 1.14% of the company's total share capital of 66 million shares [2][11] - The initial grant will consist of 617,200 shares, accounting for 0.94% of the total share capital, with a reserve of 133,700 shares [2][11] - The grant price for the restricted shares is set at 15.00 yuan per share, which is significantly lower than the average trading prices over various periods [3][19][20] Summary by Sections Incentive Plan Overview - The incentive plan is designed to establish a long-term incentive mechanism to enhance team cohesion and core competitiveness [6][24] - The plan will be executed after approval from the board and shareholders, with a maximum validity of 48 months [3][10] Grant and Vesting Conditions - The restricted shares will not confer shareholder rights until vested and cannot be transferred or used as collateral before vesting [2][21] - The vesting schedule includes three phases, with 30% vesting after 12 months, another 30% after 24 months, and the remaining 40% after 36 months [15][16] Eligible Participants - Eligible participants include directors, senior management, and key personnel deemed necessary for motivation, excluding independent directors and supervisors [4][9][10] - The plan includes the company's actual controller, Jiang Mingwu, as a participant [9][10] Performance Metrics - The performance assessment for vesting will be based on the company's revenue growth rate over the fiscal years 2025 to 2027 [22][24] - Individual performance evaluations will also influence the actual number of shares vested, categorized into four performance levels [23][24] Implementation Procedures - The plan requires a series of approvals, including from the board and shareholders, and must be publicly disclosed [25][26] - The company must complete the grant process within 60 days after shareholder approval [27][28]